Hypoxia and Preeclampsia: Increased Expression of Urocortin 2 and Urocortin 3

被引:25
|
作者
Imperatore, Alberto [1 ,2 ]
Rolfo, Alessandro [3 ]
Petraglia, Felice
Challis, John R. G. [2 ]
Caniggia, Isabella [2 ,3 ]
机构
[1] Univ Siena, Policlin S Maria delle Scotte, Dept Pediat Obstet & Reprod Med, Siena, Italy
[2] Univ Toronto, Dept Physiol Obstet & Gynecol & Med, Toronto, ON M5S 1A1, Canada
[3] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada
关键词
placenta; preeclampsia; urocortin; 2; 3; hypoxia; hypoxia-inducible factor; CORTICOTROPIN-RELEASING-FACTOR; STRESSCOPIN-RELATED PEPTIDE; IN-VITRO; HUMAN PLACENTA; CARDIOVASCULAR FUNCTION; OXYGEN; DIFFERENTIATION; RECEPTORS; TISSUES; REOXYGENATION;
D O I
10.1177/1933719110373147
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Urocortin 2 (Ucn2) and urocortin 3 (Ucn3) are new members of the corticotrophin-releasing hormone (CRH) family of peptides expressed and localized in human placenta. In the current study, we aimed to asses whether hypoxia affects placental Ucn2/Ucn3 messenger RNA (mRNA) expression and protein localization in physiological or pathological hypoxia and to evaluate whether the effect is modulated by the hypoxia-inducible factor 1 alpha (HIF-1 alpha). Methods: Early first-trimester placental specimens from elective termination of pregnancy were used for villous explants and term placental tissue were used for primary cell cultures. The samples were incubated under different oxygen conditions; parallel sets exposed to hypoxia re-oxygenation (HR). Dimethyloxalylglycine (DMOG), an HIF-1 alpha stabilizer, was used to mimic the effects of hypoxia in villous explants. Real-time polymerase chain reaction (PCR) and immunohystochemistry were performed on early pregnancy and preeclamptic (PE) placentae. mRNA levels were measured on villous explants and cell cultures incubated under different oxygen and reagent conditions. Results: Both Ucn2 and Ucn3 mRNA expression was significantly higher at 6 to 9 weeks of gestation than 10 to 12 wks and in primary trophoblast cell cultures and explants exposed to low O-2 tension (3%) compared to 20% O-2. Strong Ucn2/Ucn3 immunoreactivity was present in trophoblast villi from 6 weeks placentae. Ucn2 immunostaining was stronger in early PE (E-PE) samples relative to controls whereas Ucn3 showed stronger immunoreactivity in late-PE (L-PE) placentae. Only Ucn2 transcript levels increased in HR explants. Ucn2 and Ucn3 expression by first-trimester explants was significantly greater in the presence of DMOG. All PE placentae expressed significantly higher Ucn2 and Ucn3 mRNA compared to controls. Discussion: Placental Ucn2 and Ucn3 expression is sensitive to O-2 tensions and mediated by HIF-1 alpha. During early pregnancy, Ucn2/Ucn3 may influence trophoblast proliferation and establishment of pregnancy. In PE placentae, the increased expression of both peptides may reflect a response to the oxidative stress.
引用
收藏
页码:833 / 843
页数:11
相关论文
共 50 条
  • [1] Hypoxia and Preeclampsia: Increased Expression of Urocortin 2 and Urocortin 3
    Alberto Imperatore
    Alessandro Rolfo
    Felice Petraglia
    John R G Challis
    Isabella Caniggia
    Reproductive Sciences, 2010, 17 : 833 - 843
  • [2] Urocortin 2 and urocortin 3 mRNA and protein expression are increased in preeclamptic placentae specimens.
    Imperatore, Alberto
    Rolfo, Alessandro
    Petraglia, Felice
    Challis, John R. G.
    Caniggia, Isabella
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 78A - 78A
  • [3] Hypoxia enhances the expression of human Urocortin 2 via HIF1
    Buehler, K.
    Dieterle, T.
    Brink, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 111 - 111
  • [4] Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response
    Novembri, R.
    Luisi, S.
    Carrarelli, P.
    Rocha, A. L. L.
    Toti, P.
    Reis, F. M.
    Florio, P.
    Petraglia, F.
    HUMAN REPRODUCTION, 2011, 26 : I207 - I207
  • [5] Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure
    Stirrat, Colin G.
    Venkatasubramanian, Sowmya
    Pawade, Tania
    Mitchell, Andrew J.
    Shah, Anoop S.
    Lang, Ninian N.
    Newby, David E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 974 - 982
  • [6] Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes
    Imperatore, Alberto
    Florio, Pasquale
    Torres, Paulo B.
    Torricelli, Michela
    Galleri, Letizia
    Toti, Paolo
    Occhini, Rossella
    Picciolini, Enrico
    Vale, Wylie
    Petraglia, Felice
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) : 288 - 295
  • [7] Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response
    Novembri, Romina
    Carrarelli, Patrizia
    Toti, Paolo
    Rocha, Ana Luiza L.
    Borges, Lavinia E.
    Reis, Fernando M.
    Piomboni, Paola
    Florio, Pasquale
    Petraglia, Felice
    MOLECULAR HUMAN REPRODUCTION, 2011, 17 (09) : 587 - 593
  • [8] Urocortin 2 and Urocortin 3 mRNA Expression and Peptide Localization Changes in Trophoblast Specimens throughout Pregnancy and Birth.
    Imperatore, Alberto
    Galleri, Letizia
    Petraglia, Felice
    Challis, John R. G.
    Caniggia, Isabella
    REPRODUCTIVE SCIENCES, 2009, 16 (03) : 160A - 160A
  • [9] Stressors affect urocortin 1 and urocortin 2 gene expression in rat spleen: The role of glucocorticoids
    Tillinger, Andrej
    Padova, Alexandra
    Mravec, Boris
    Tomova, Aleksandra
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 336
  • [10] Cardiovascular effects of Urocortin 2 and Urocortin 3 in patients with heart failure and healthy volunteers
    Stirrat, Colin G.
    Ventakasubramanian, Sowmya
    Pawade, Tania
    Mitchell, Andrew J.
    Shah, Anoop
    Lang, Ninian N.
    Newby, David E.
    SCOTTISH MEDICAL JOURNAL, 2016, 61 (04) : NP45 - NP47